Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -317,418 | -235,937 | -168,099 | -149,291 | -59,437 |
| Depreciation Amortization | -1,931 | 571 | 2,959 | 3,668 | 776 |
| Accounts payable and accrued liabilities | -8,955 | 22,970 | -1,235 | 13,702 | 8,567 |
| Other Working Capital | -19,491 | 26,307 | -5,379 | 9,256 | 5,112 |
| Other Operating Activity | 55,426 | -2,069 | 18,109 | 3,102 | -1,526 |
| Operating Cash Flow | $-292,369 | $-188,158 | $-153,645 | $-119,563 | $-46,508 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -317,443 | -44,262 | -121,176 | -236,721 | -44,500 |
| PPE Investments | -2,376 | -729 | -3,067 | -3,618 | -1,161 |
| Purchase Of Investment | 105,180 | 126,473 | 208,291 | 98,010 | N/A |
| Sale Of Investment | 10,563 | 1,829 | 3,154 | 4,437 | N/A |
| Investing Cash Flow | $-204,076 | $83,311 | $87,202 | $-137,892 | $-45,661 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 9,936 |
| Debt Repayment | N/A | N/A | N/A | N/A | -10,000 |
| Common Stock Issued | 809,895 | 54,322 | 37,390 | 157,821 | 246,418 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 134,336 |
| Financing Cash Flow | $809,895 | $54,322 | $37,390 | $157,821 | $380,690 |
| Beginning Cash Position | 123,941 | 174,466 | 203,519 | 303,153 | 14,632 |
| End Cash Position | 437,391 | 123,941 | 174,466 | 203,519 | 303,153 |
| Net Cash Flow | $313,450 | $-50,525 | $-29,053 | $-99,634 | $288,521 |
| Free Cash Flow | |||||
| Operating Cash Flow | -292,369 | -188,158 | -153,645 | -119,563 | -46,508 |
| Capital Expenditure | -2,376 | -729 | -3,067 | -3,618 | -1,161 |
| Free Cash Flow | -294,745 | -188,887 | -156,712 | -123,181 | -47,669 |